Genetic detection of liver micrometastases that are undetectable histologically

Journal of Surgical Research

Volumn 106, Issue 1, 2002, Pages 124-130

  Ikawa, Koichi ^a   Terashima, Yoshiyasu ^a   Sasaki, Kenji ^a   Tashiro, Seiki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Genetic diagnosis; Liver biopsy; Polymerase chain reaction; Splenic injection

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER GRAFT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN CELL; LIVER; LIVER METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PREDICTION; PRIORITY JOURNAL; SPLEEN; SPLENECTOMY; SURFACE PROPERTY;

EID: 0036374277     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2002.6459     Document Type: Article

References (27)

1. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases
2. The clinical correlation of an autopsy study of recurrent colorectal cancer
3. Metastases: Incidence, detection, and evaluation without histologic confirmation
4. Resection of colorectal liver metastases
5. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma
6. Resection of liver metastases from colorectal cancer. Indications and results
7. Hepatic resection in 128 patients: A 24-year experience
8. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants
9. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence
10. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie
11. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
12. Hepatic arterial floxuridine and leucovorin for un-resectable liver metastases from colorectal carcinoma. New dose schedules and survival update
13. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin
14. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases
15. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multi-centre randomised trial
16. A phase III multicenter randomized trial comparing CPT-11 to infusional 5FU regimen inpatients with advanced colorectal cancer after 5FU failure
17. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method
18. Genetic diagnosis of lymph-node metastasis in colorectal cancer
19. Genetic detection of colorectal cancer cells in circulation and lymph nodes
20. Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease
21. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
22. Illegitimate villin transcripts in normal bone marrow precludes detection of colon cancer micrometastases
23. Detection of carcinoembryonic antigen mRNA in the mesenteric vein of patients with resectable colorectal cancer
24. State of art: Molecular diagnosis in colorectal cancer
25. Allelotype of breast cancer: Cumulative allele losses promote tumor progression in primary breast cancer
26. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer
27. Predictive value of genetic diagnosis for cancer micrometastasis: Histologic and experimental appraisal